Harbor Health Care ETF
Harbor Health Care ETF reported 49 holdings worth US$41.2M as of Jul 31, 2026 (Form N-PORT)
As of Jul 31, 2026 · Filed Sep 25, 2026
Harbor Health Care ETF reported 49 holdings worth US$41.2M as of Jul 31, 2026. Largest: Eli Lilly And Company, Ascendis Pharma A/s and Gilead Sciences, Inc. Filed Sep 25, 2026 (Form N-PORT).
- Holdings
- 49
- Value as reported
- US$41.2M
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|
| Eli Lilly And Company | 7,455 | US$8.56M | 20.8% |
| Ascendis Pharma A/s | 22,993 | US$5.61M | 13.6% |
| Gilead Sciences, Inc. | 16,135 | US$2.1M | 5.1% |
| Rhythm Pharmaceuticals, Inc. | 16,680 | US$1.66M | 4.0% |
| Abbvie Inc. | 5,079 | US$1.27M | 3.1% |
| Intuitive Surgical, Inc. | 3,300 | US$1.17M | 2.8% |
| Cencora, Inc. | 3,634 | US$1.13M | 2.7% |
| Revolution Medicines, Inc. | 5,583 | US$1.05M | 2.5% |
| Insmed Incorporated | 10,513 | US$1.04M | 2.5% |
| Merck & Company, Inc. | 7,807 | US$1.02M | 2.5% |
| Boston Scientific Corporation | 21,166 | US$989K | 2.4% |
| Natera, Inc. | 3,475 | US$930K | 2.3% |
| Abivax Sa | 7,139 | US$892K | 2.2% |
| Insulet Corporation | 5,226 | US$864K | 2.1% |
| Argenx Se | 1,001 | US$855K | 2.1% |
| Vaxcyte, Inc. | 15,695 | US$849K | 2.1% |
| Mckesson Corporation | 974 | US$834K | 2.0% |
| Danaher Corporation | 3,647 | US$711K | 1.7% |
| Guardant Health, Inc. | 3,925 | US$636K | 1.5% |
| Novo Nordisk A/s Class B | 12,952 | US$602K | 1.5% |
| Idexx Laboratories, Inc. | 1,034 | US$578K | 1.4% |
| Unitedhealth Group Incorporated | 1,382 | US$573K | 1.4% |
| Ptc Therapeutics, Inc. | 7,913 | US$538K | 1.3% |
| Vertex Pharmaceuticals Incorporated | 1,053 | US$502K | 1.2% |
| Alnylam Pharmaceuticals, Inc. | 2,430 | US$499K | 1.2% |
| Thermo Fisher Scientific Inc | 835 | US$480K | 1.2% |
| Adaptive Biotechnologies Corporation | 17,855 | US$403K | 0.98% |
| Madrigal Pharmaceuticals, Inc. | 817 | US$382K | 0.93% |
| Praxis Precision Medicines, Inc. | 1,221 | US$376K | 0.91% |
| Dexcom, Inc. | 3,979 | US$332K | 0.81% |
| Radnet, Inc. | 5,146 | US$328K | 0.80% |
| Penumbra, Inc. | 987 | US$317K | 0.77% |
| Relay Therapeutics, Inc. | 14,039 | US$264K | 0.64% |
| Oruka Therapeutics, Inc. | 2,546 | US$246K | 0.60% |
| Irhythm Holdings, Inc. | 2,025 | US$237K | 0.58% |
| Viatris Inc. | 13,424 | US$236K | 0.57% |
| Newamsterdam Pharma Company N.v. | 7,656 | US$213K | 0.52% |
| Xenon Pharmaceuticals Inc. | 3,362 | US$211K | 0.51% |
| Indivior Pharmaceuticals, Inc. | 5,144 | US$206K | 0.50% |
| Axsome Therapeutics, Inc. | 929 | US$203K | 0.49% |
| Inventiva Sa | 33,996 | US$152K | 0.37% |
| Sophia Genetics Sa | 24,267 | US$138K | 0.33% |
| Ionis Pharmaceuticals, Inc. | 1,631 | US$84,437 | 0.20% |
| Nuvalent, Inc. | 0 | US$0 | 0.00% |
| Scholar Rock Holding Corporation | 0 | US$0 | 0.00% |
| Genedx Holdings Corp. | 0 | US$0 | 0.00% |
| Immunovant, Inc. | 0 | US$0 | 0.00% |
| Bio-techne Corp | 0 | US$0 | 0.00% |
| Avalo Therapeutics, Inc. | 0 | US$0 | 0.00% |
Source
View original at SEC
Related